Home4016 • TADAWUL
add
Middle East Pharmaceutical Inds Co SJSC
Nakaraang pagsara
SAR 114.60
Sakop ng araw
SAR 112.30 - SAR 117.50
Sakop ng taon
SAR 108.00 - SAR 140.60
Market cap
2.34B SAR
Average na Volume
39.86K
P/E ratio
24.07
Dividend yield
2.01%
Primary exchange
TADAWUL
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (SAR) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 107.95M | 33.17% |
Gastos sa pagpapatakbo | 51.48M | 31.26% |
Net na kita | 8.28M | 114.06% |
Net profit margin | 7.67 | 60.80% |
Kita sa bawat share | — | — |
EBITDA | 13.78M | 111.63% |
Aktuwal na % ng binabayarang buwis | 15.69% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SAR) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 19.42M | 40.70% |
Kabuuang asset | 565.61M | 14.49% |
Kabuuang sagutin | 194.27M | 15.74% |
Kabuuang equity | 371.33M | — |
Natitirang share | 20.00M | — |
Presyo para makapag-book | 6.17 | — |
Return on assets | 4.73% | — |
Return on capital | 6.06% | — |
Cash Flow
Net change in cash
| (SAR) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 8.28M | 114.06% |
Cash mula sa mga operasyon | 24.80M | 184.07% |
Cash mula sa pag-invest | -8.39M | -113.91% |
Cash mula sa financing | -21.26M | -183.08% |
Net change in cash | -4.85M | 38.06% |
Malayang cash flow | 12.58M | 132.20% |
Tungkol
Itinatag
1998
Headquarters
Website
Mga Empleyado
632
